Cited by 557Pharmacological Receptor Mechanisms and EffectsPsychedelics and Drug StudiesReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

Open access

Fontanilla, Dominique, Johannessen, Molly, Hajipour, Abdol R., Cozzi, Nicholas V., Jackson, Meyer B., Ruoho, Arnold E.·2009·Science

DOI 10.1126/science.1166127PMC PMC2947205

Open this paper in CoChat — free account

Abstract

The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid receptor, the sigma-1 receptor binds a vast number of synthetic compounds but does not bind opioid peptides; it is currently considered an orphan receptor. The sigma-1 receptor pharmacophore includes an alkylamine core, also found in the endogenous compound N,N -dimethyltryptamine (DMT). DMT acts as a hallucinogen, but its receptor target has been unclear. DMT bound to sigma-1 receptors and inhibited voltage-gated sodium ion (Na + ) channels in both native cardiac myocytes and heterologous cells that express sigma-1 receptors. DMT induced hypermobility in wild-type mice but not in sigma-1 receptor knockout mice. These biochemical, physiological, and behavioral experiments indicate that DMT is an endogenous agonist for the sigma-1 receptor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.1166127

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Bootman, M. D., Missiaen, L., Parys, J. B., SMEDT, H. D., & Casteels, R. (1995) · Biochemical Journal · doi:10.1042/bj3060445 · Cited by 5,131
Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival
Hayashi, T., & Su, T.-P. (2007) · Cell · doi:10.1016/j.cell.2007.08.036 · Cited by 1,826
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912
Steroid Binding at σ Receptors Suggests a Link Between Endocrine, Nervous, and Immune Systems
Su, T., London, E. D., & Jaffe, J. H. (1988) · Science · doi:10.1126/science.2832949 · Cited by 548
The Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit
Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 400
Self-citation
??-1 Receptor Ligands
Hayashi, T., & Su, T. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00001 · Cited by 295
Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors
Lindemann, L., Ebeling, M., Kratochwil, N. A., Bunzow, J. R., Grandy, D. K., & Hoener, M. C. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.010 · Cited by 278
The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain
Burchett, S. A., & Hicks, T. P. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.003 · Cited by 227
Psychotomimetic N -Methylated Tryptamines: Formation in Brain in vivo and in vitro
Saavedra, J. M., & Axelrod, J. (1972) · Science · doi:10.1126/science.175.4028.1365 · Cited by 186
Enzymatic formation of psychotomimetic metabolites from normally occurring compounds
Axelrod, J. (1961) · Science · doi:10.1126/science.134.3475.343 · Cited by 184

Show all 30 references

Research works printed but not linked: 1

F. Franzen, H. Gross, Nature206, 1052 (1965).

Sorted by citations

Items 101–200 of 557

Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users
Cakic, V., Potkonyak, J., & Marshall, A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.015 · Cited by 72
LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.
Barker, S. A., Borjigin, J., Lomnicka, I., & Strassman, R. (2013) · Biomedical Chromatography · doi:10.1002/bmc.2981 · Cited by 72
Psychedelics as a novel approach to treating autoimmune conditions
Thompson, C., & Szabó, A. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.10.001 · Cited by 71
Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders
Maurice, T. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1838483 · Cited by 71
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
Sałaciak, K., & Pytka, K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.037 · Cited by 71
The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
Sahlholm, K., Århem, P., Fuxé, K., & Marcellino, D. J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.3 · Cited by 71
A Role for Sigma Receptors in Stimulant Self Administration and Addiction
Katz, J. L., Su, T., Hiranita, T., Hayashi, T., Tanda, G., Kopajtic, T. A., & Tsai, S. (2011) · Pharmaceuticals · doi:10.3390/ph4060880 · Cited by 74
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
Zamberlan, F., Sanz, C., Martínez Vivot, R., Pallavicini, C., Erowid, F., Erowid, E., & Tagliazucchi, E. (2018) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2018.00054 · Cited by 71
Choline Is an Intracellular Messenger Linking Extracellular Stimuli to IP3-Evoked Ca2+ Signals through Sigma-1 Receptors
Brailoiu, E., Chakraborty, S., Brailoiu, G. C., Zhao, P., Barr, J. L., Ilies, M. A., Unterwald, E. M., Abood, M. E., & Taylor, C. W. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.051 · Cited by 71
Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine
Wang, S., Wu, H.-E., Yasui, Y., Geva, M., Hayden, M. R., Maurice, T., Cozzolino, M., & Su, T. (2022) · Autophagy · doi:10.1080/15548627.2022.2063003 · Cited by 71
σ-1 receptors in major depression and anxiety
Kulkarni, S. K., & Dhir, A. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.40 · Cited by 70
Design, Synthesis, and Structure−Affinity Relationships of RegioisomericN-Benzyl Alkyl Ether Piperazine Derivatives as σ-1 Receptor Ligands
Moussa, I. A., Banister, S. D., Beinat, C., Giboureau, N., Reynolds, A. J., & Kassiou, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100639f · Cited by 70
Sigma-2 Receptor Ligands: Neurobiological Effects
Guo, L., & Zhen, X. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163607 · Cited by 66
The Sigma-1 Receptor Binds to the Nav1.5 Voltage-gated Na+ Channel with 4-Fold Symmetry
Balasuriya, D., Stewart, A. P., Crottès, D., Borgèse, F., Soriani, O., & Edwardson, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382077 · Cited by 69
Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic Cells
Crottès, D., Martial, S., Rapetti‐Mauss, R., Pisani, D. F., Loriol, C., Pellissier, B., Martin, P., Chevet, É., Borgèse, F., & Soriani, O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226738 · Cited by 69
N,N -dimethyltryptamine and the pineal gland: Separating fact from myth
Nichols, D. E. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117736919 · Cited by 69
Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
Rijsketic, D. R., Wu, L., Wu, J., Kim, D. B., Rammes, G., Geva, M., Hayden, M. R., & Борисович, Б. И. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.022 · Cited by 72
The morphological and functional characteristics of the pineal gland
Gheban, B., Rosca, I. A., & Crişan, M. (2019) · Medicine and Pharmacy Reports · doi:10.15386/mpr-1235 · Cited by 68
The sigma-1 receptor: a regulator of cancer cell electrical plasticity?
Crottès, D., Guizouarn, H., Martin, P., Borgèse, F., & Soriani, O. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00175 · Cited by 67
Insights into S-adenosyl-l-methionine (SAM)-dependent methyltransferase related diseases and genetic polymorphisms
Li, J., Sun, C., Cai, W., Li, J., Rosen, B. P., & Chen, J. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108396 · Cited by 68
Demonstration of a Direct Interaction between σ-1 Receptors and Acid-Sensing Ion Channels
Carnally, S. M., Johannessen, M., Henderson, R. M., Jackson, M. B., & Edwardson, J. M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4293 · Cited by 67
Self-citation
The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens
Canal, C. E., & Murnane, K. S. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677104 · Cited by 73
Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor.
Mavlyutov, T. A., Nickells, R. W., & Guo, L. (2011) · PubMed Central · Cited by 66
Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy
Mégalizzi, V., Mercier, M. L., & Decaestecker, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20218 · Cited by 66
Sigma 1 receptor: A novel therapeutic target in retinal disease
Smith, S. B., Wang, J., Cui, X., Mysona, B. A., Zhao, J., & Bollinger, K. E. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.07.003 · Cited by 67
Subcellular Localization of the Sigma-1 Receptor in Retinal Neurons — an Electron Microscopy Study
Mavlyutov, T. A., Epstein, M. L., & Guo, L. (2015) · Scientific Reports · doi:10.1038/srep10689 · Cited by 65
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics
Jain, M. K., Gumpper, R. H., Slocum, S. T., Schmitz, G. P., Madsen, J. S., Tummino, T. A., Suomivuori, C., Huang, X.-P., Shub, L., DiBerto, J. F., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.06.012 · Cited by 74
Cholesterol at the Endoplasmic Reticulum: Roles of the Sigma-1 Receptor Chaperone and Implications thereof in Human Diseases
Hayashi, T., & Su, T. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_13 · Cited by 66
Chloroquine inhibits glutamate‐induced death of a neuronal cell line by reducing reactive oxygen species through sigma‐1 receptor
Hirata, Y., Yamamoto, H., Atta, M. S. M., Mahmoud, S., Oh‐hashi, K., & Kiuchi, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07464.x · Cited by 65
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 72
Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels
Johannessen, M., Fontanilla, D., Mavlyutov, T. A., Ruoho, A. E., & Jackson, M. B. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00383.2010 · Cited by 64
Self-citation
From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency
Bortolato, M., Floris, G., & Shih, J. C. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1888-y · Cited by 66
Sigma-1 (σ1) Receptor in Memory and Neurodegenerative Diseases
Maurice, T., & Goguadze, N. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_15 · Cited by 65
Molecular Interplay Between the Sigma-1 Receptor, Steroids, and Ion Channels
Morales‐Lázaro, S. L., González‐Ramírez, R., & Rosenbaum, T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00419 · Cited by 63
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Barker, S. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06065-0 · Cited by 58
Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells
Tourino, M. C., de Oliveira, E. M., Bellé, L. P., Knebel, F. H., Albuquerque, R. C., Dörr, F. A., Okada, S. S., Migliorini, S., Soares, I. S., & Čampa, A. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2980 · Cited by 60
Sigma Receptor Agonist 2-(4-Morpholinethyl)1 Phenylcyclohexanecarboxylate (Pre084) Increases GDNF and BiP Expression and Promotes Neuroprotection after Root Avulsion Injury
Penas, C., Pascual-Font, A., Mancuso, R., Forés, J., Casas, C., & Navarro, X. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1674 · Cited by 61
SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness
Crottès, D., Rapetti‐Mauss, R., Alcaraz‐Pérez, F., Tichet, M., Gariano, G., Martial, S., Guizouarn, H., Pellissier, B., Loubat, A., Popa, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1465 · Cited by 60
Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors
Ramzy, L., Metwally, A. A., Nasr, M., & Awad, G. A. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67748-2 · Cited by 60
Chemical composition of traditional and analog Ayahuasca
Kaasik, H., Souza, R. C. Z., Zandonadi, F. S., Tófoli, L. F., & Sussulini, A. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1815911 · Cited by 59
SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation
Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., O'Callaghan, J. P., Huber, J. D., & Matsumoto, R. R. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.020 · Cited by 59
ER-Mitochondria Crosstalk during Cerebral Ischemia: Molecular Chaperones and ER-Mitochondrial Calcium Transfer
Ouyang, Y., & Giffard, R. G. (2012) · International Journal of Cell Biology · doi:10.1155/2012/493934 · Cited by 59
Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
Graziano, S., Orsolini, L., Rotolo, M. C., Tittarelli, R., Schifano, F., & Pichini, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666161031144427 · Cited by 60
Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions
Bhuiyan, M. S., Tagashira, H., Shioda, N., & Fukunaga, K. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.509348 · Cited by 56
Activation of σ-Receptors Induces Binge-like Drinking in Sardinian Alcohol-Preferring Rats
Sabino, V., Cottone, P., Blasio, A., Iyer, M. R., Steardo, L., Rice, K. C., Conti, B., Koob, G. F., & Zorrilla, E. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.5 · Cited by 56
Allosteric Modulators of Sigma-1 Receptor: A Review
Vavers, E., Zvejniece, L., Maurice, T., & Dambrova, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00223 · Cited by 54
Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction
Buch, S. J., Yao, H., Guo, M., Mori, T., Su, T., & Wang, J. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9297-0 · Cited by 55
Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses
Sahlholm, K., Sijbesma, J. W. A., Maas, B., Kwizera, C., Marcellino, D. J., Ramakrishnan, N. K., Dierckx, R., Elsinga, P. H., & van Waarde, A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3997-8 · Cited by 55
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders
Lowe, H. I. C., Toyang, N. J., Steele, B., Grant, J., Ali, A., Gordon, L., & Ngwa, W. F. (2022) · Molecules · doi:10.3390/molecules27082520 · Cited by 58
Psychedelics as Transformative Therapeutics
Roth, B. L., & Gumpper, R. H. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230172 · Cited by 57
A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF®)
Balasuriya, D., D’Sa, L., Talker, R., Dupuis, E., Maurin, F., Martin, P., Borgèse, F., Soriani, O., & Edwardson, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603506 · Cited by 55
Noncompetitive Inhibition of Indolethylamine- N -methyltransferase by N , N -Dimethyltryptamine and N , N -Dimethylaminopropyltryptamine
Chu, U. B., Vorperian, S. K., Satyshur, K. A., Eickstaedt, K., Cozzi, N. V., Mavlyutov, T. A., Hajipour, A. R., & Ruoho, A. E. (2014) · Biochemistry · doi:10.1021/bi500175p · Cited by 54
Self-citation
APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum
Mavlyutov, T. A., Yang, H. M., Epstein, M. L., Ruoho, A. E., Yang, J., & Guo, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17906 · Cited by 51
Self-citation
Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer's disease by positive modulation of σ1 receptors
Maurice, T., Volle, J., Strehaïano, M., Crouzier, L., Pereira, C., Kaloyanov, N., Virieux, D., & Pirat, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.026 · Cited by 56
Late-Onset Inner Retinal Dysfunction in Mice Lacking Sigma Receptor 1 (σR1)
Ha, Y., SAUL, A. B., Tawfik, A. M., Williams, C., Bollinger, K. E., Smith, R. G., Tachikawa, M., Zorrilla, E. P., Ganapathy, V., & Smith, S. B. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8169 · Cited by 53
The Lifetime of UDP-galactose:Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones
Hayashi, T., Hayashi, E., Fujimoto, M., Sprong, H., & Su, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380444 · Cited by 55
The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in Rats
Shenoy, P. A., Kuo, A., Vetter, I., & Smith, M. T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00286 · Cited by 52
NPS: Medical Consequences Associated with Their Intake
Schifano, F., Orsolini, L., Papanti, D., & Corkery, J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_15 · Cited by 56
Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion
Nakamura, Y., Dryanovski, D. I., Kimura, Y., Jackson, S. N., Woods, A. S., Yasui, Y., Tsai, S., Patel, S., Covey, D. P., Su, T., et al. (2019) · eLife · doi:10.7554/elife.47209 · Cited by 52
Targeting sigma-1 receptor signaling by endogenous ligands for cardioprotection
Bhuiyan, M. S., & Fukunaga, K. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.546350 · Cited by 52
Exploring DMT: Endogenous role and therapeutic potential
Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 55
Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine
McIlhenny, E. H., Riba, J., Barbanoj, M. J., Strassman, R. J., & Barker, S. A. (2010) · Biomedical Chromatography · doi:10.1002/bmc.1551 · Cited by 53
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases
Zhemkov, V., Geva, M., Hayden, M. R., & Борисович, Б. И. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084082 · Cited by 50
The Sigma Enigma:In Vitro/in SilicoSite-Directed Mutagenesis Studies Unveil σ1Receptor Ligand Binding
Brune, S., Schepmann, D., Klempnauer, K., Marson, D., Col, V. D., Laurini, E., Fermeglia, M., Wünsch, B., & Pricl, S. (2014) · Biochemistry · doi:10.1021/bi401575g · Cited by 50
Evaluation of Spirocyclic 3-(3-Fluoropropyl)-2-benzofurans as σ1 Receptor Ligands for Neuroimaging with Positron Emission Tomography
Maestrup, E. G., Fischer, S., Wiese, C., Schepmann, D., Hiller, A., Deuther‐Conrad, W., Steinbach, J., Wünsch, B., & Brust, P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900909e · Cited by 50
Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism
Mitchell, J., & Anderson, B. T. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01656-7 · Cited by 55
Early Development of Sigma-Receptor Ligands
Narayanan, S., Bhat, R., Mésangeau, C., Poupaert, J. H., & McCurdy, C. R. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.279 · Cited by 49
Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
Georgiadis, M., Karoutzou, O., Foscolos, A., & Papanastasiou, I. P. (2017) · Molecules · doi:10.3390/molecules22091408 · Cited by 49
Targeting sigma receptors: novel medication development for drug abuse and addiction
Matsumoto, R. R. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.18 · Cited by 49
Deorphanizing the human transmembrane genome: A landscape of uncharacterized membrane proteins
Babcock, J. J., & Li, M. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.142 · Cited by 44
The effects of sigma (σ1) receptor‐selective ligands on muscarinic receptor antagonist‐induced cognitive deficits in mice
Malik, M., Rangel‐Barajas, C., Sumien, N., Su, C., Singh, M., Chen, Z., Huang, R., Meunier, J., Maurice, T., Mach, R. H., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13076 · Cited by 48
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_107 · Cited by 50
In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine
Vitale, A. A., Pomilio, A. B., Cañellas, C. O., Vitale, M. G., Putz, E. M., & Ciprian-Ollivier, J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083246 · Cited by 48
Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression
Falchi-Carvalho, M., Palhano-Fontes, F., Wießner, I., Barros, H., Bolcont, R., Laborde, S., Silva, S. R. B., Montanini, D., Barbosa, D. C., Teixeira, E., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02091-6 · Cited by 52
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics
Remesic, M., Hruby, V. J., Porreca, F., & Lee, Y. S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00090 · Cited by 48
Sigma (σ) Receptors as Potential Therapeutic Targets to Mitigate Psychostimulant Effects
Matsumoto, R. R., Nguyen, L., Kaushal, N., & Robson, M. J. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00009-3 · Cited by 47
N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
Cheng, D., Lei, Z., Chu, K., Lam, O. J. H., Chiang, C. Y., & Zhang, Z.-J. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01462-3 · Cited by 47
Using sigma-ligands as part of a multi-receptor approach to target diseases of the brain
Brimson, J. M., Brimson, S., Chomchoei, C., & Tencomnao, T. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1805435 · Cited by 46
Structure of the σ1 Receptor and Its Ligand Binding Site
Brune, S., Pricl, S., & Wünsch, B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400660u · Cited by 46
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Mastinu, A., Anyanwu, M., Carone, M., Abate, G., Bonini, S. A., Peron, G., Tirelli, E., Pucci, M., Ribaudo, G., Oselladore, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021329 · Cited by 52
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands
Laurini, E., Marson, D., Col, V. D., Fermeglia, M., Mamolo, M. G., Zampieri, D., Vio, L., & Pricl, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300233y · Cited by 45
Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems
Couly, S., Goguadze, N., Yasui, Y., Kimura, Y., Wang, S., Sharikadze, N., Wu, H.-E., & Su, T. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00983-3 · Cited by 44
Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
Szabó, A., & Frecska, E. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.179041 · Cited by 45
Sigma receptors and neurological disorders
Piechal, A., Jakimiuk, A. A., & Mirowska-Guzel, D. M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00310-7 · Cited by 44
Pharmahuasca and DMT rescue ROS production and differentially expressed genes observed after predator and psychosocial stress: Relevance to human PTSD
Kelley, D. P., Venable, K., Destouni, A., Billac, G., Ebenezer, P., Stadler, K., Nichols, C., Barker, S., & Francis, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00660 · Cited by 42
Potential use of ayahuasca in grief therapy
González, D., Carvalho, M., Cantillo, J., Aixalá, M., & Farré, M. (2019) · OMEGA - Journal of Death and Dying · doi:10.1177/0030222817710879 · Cited by 44
Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine
Yasui, Y., & Su, T. (2016) · Journal of Drug and Alcohol Research · doi:10.4303/jdar/235970 · Cited by 42
Discovery of Gut Bacteria Specific to Alzheimer’s Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics
Paley, E. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190873 · Cited by 41
The Shipibo ceremonial use of ayahuasca to promote well-being: An observational study
Gonzalez, D., Cantillo, J., Perez, I., Carvalho, M., Aronovich, A., Farre, M., Feilding, A., Obiols, J. E., & Bouso, J. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623923 · Cited by 40
Methylphenidate Enhances NMDA-Receptor Response in Medial Prefrontal Cortex via Sigma-1 Receptor: A Novel Mechanism for Methylphenidate Action
Zhang, C.-L., Feng, Z.-J., Liu, Y., Ji, X.-H., Peng, J.-Y., Zhang, X.-H., Zhen, X.-C., & Li, B.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051910 · Cited by 41
Sigma-1 receptor expression in the dorsal root ganglion: Reexamination using a highly specific antibody
Mavlyutov, T. A., Duellman, T., Kim, H. T., Epstein, M. L., Leese, C., Davletov, B. A., & Yang, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.030 · Cited by 41
Targeting Nanocarriers with Anisamide: Fact or Artifact?
Dasargyri, A., Kümin, C. D., & Leroux, J. (2016) · Advanced Materials · doi:10.1002/adma.201603451 · Cited by 41
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
James, E., Keppler, J., Robertshaw, T. L., & Sessa, B. (2022) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2835 · Cited by 50
Self-Administration of Cocaine Induces Dopamine-Independent Self-Administration of Sigma Agonists
Hiranita, T., Mereu, M., Soto, P. L., Tanda, G., & Katz, J. L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.224 · Cited by 42
Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models
Lee, P.-T., Liévens, J.-C., Wang, S., Chuang, J., Khalil, B., Wu, H.-E., Chang, W., Maurice, T., & Su, T. (2020) · Nature Communications · doi:10.1038/s41467-020-19396-3 · Cited by 41
Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology
Luke, D. P. (2011) · Greenwich Academic Literature Archive (University of Greenwich) · Cited by 40
Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats
Killinger, B. A., Peet, M. M., & Baker, L. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.014 · Cited by 38
Green, efficient and large-scale synthesis of benzimidazoles, benzoxazoles and benzothiazoles derivatives using ligand-free cobalt-nanoparticles: as potential anti-estrogen breast cancer agents, and study of their interactions with estrogen receptor by molecular docking
Hajipour, A. R., Khorsandi, Z., Mortazavi, M., & Farrokhpour, H. (2015) · RSC Advances · doi:10.1039/c5ra22207a · Cited by 38
Self-citation
A role for sigma receptors in stimulant self-administration and addiction
Katz, J. L., Hong, W. C., Hiranita, T., & Su, T. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000209 · Cited by 38
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Hashimoto, K., Zhao, M., Zhu, T., Wang, X., & Yang, J. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.07.001 · Cited by 38

Authors: Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E.
Affiliations: University of Wisconsin–Madison (US)
Corresponding author: Ruoho, Arnold E.
ORCID: Hajipour, Abdol R.
Cozzi, Nicholas V.
Jackson, Meyer B.
Ruoho, Arnold E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2009-02-13
Volume: 323
Issue: 5916
Pages: 934-937
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1166127
PMC: PMC2947205
OpenAlex: W2125368083
Cited by: 535
References: 30
Citations by year: 2026: 27 · 2025: 29 · 2024: 31 · 2023: 26 · 2022: 33 · 2021: 25 · 2020: 37 · 2019: 30 · 2018: 24 · 2017: 38 · 2016: 32 · 2015: 31 · 2014: 34 · 2013: 23 · 2012: 32
FWCI: 16.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Mental Health (R01MH065503)
National Institute on Drug Abuse (F31DA022932)
National Institute of General Medical Sciences (T32 GM08688, T32GM008688)
National Institute of Neurological Disorders and Stroke (NS 30016, R01NS030016, R37NS030016)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: N,N-dimethyltryptamine, sigma-1 receptor, hallucinogens, orphan receptors, voltage-gated sodium channels, cardiomyocytes, receptor knockout mice, alkylamine ligands
MeSH terms: Sigma-1 Receptor, Animals, Cell Line, Cells, Cultured, Chlorocebus aethiops, N,N-Dimethyltryptamine, Guinea Pigs, Hallucinogens, Ligands, Mice, Inbred C57BL, Myocardium, Tryptamines, Receptors, sigma, Mice, Knockout, COS Cells, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks